178 related articles for article (PubMed ID: 10342716)
1. Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
Harigai M; Hara M; Fukasawa C; Nakazawa S; Kawaguchi Y; Kamatani N; Kashiwazaki S
Lupus; 1999; 8(3):227-33. PubMed ID: 10342716
[TBL] [Abstract][Full Text] [Related]
2. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
[TBL] [Abstract][Full Text] [Related]
3. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Koshy M; Berger D; Crow MK
J Clin Invest; 1996 Aug; 98(3):826-37. PubMed ID: 8698875
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
6. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
[TBL] [Abstract][Full Text] [Related]
9. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.
Vakkalanka RK; Woo C; Kirou KA; Koshy M; Berger D; Crow MK
Arthritis Rheum; 1999 May; 42(5):871-81. PubMed ID: 10323442
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner.
Xu H; Liu J; Cui X; Zuo Y; Zhang Z; Li Y; Tao R; Li Y; Pang J
Cell Immunol; 2015 May; 295(1):46-51. PubMed ID: 25748125
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
Marken J; Muralidharan S; Giltiay NV
Arthritis Res Ther; 2021 Jan; 23(1):5. PubMed ID: 33407802
[TBL] [Abstract][Full Text] [Related]
13. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis.
Vazgiourakis VM; Zervou MI; Choulaki C; Bertsias G; Melissourgaki M; Yilmaz N; Sidiropoulos P; Plant D; Trouw LA; Toes RE; Kardassis D; Yavuz S; Boumpas DT; Goulielmos GN
Ann Rheum Dis; 2011 Dec; 70(12):2184-90. PubMed ID: 21914625
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
15. The soluble CD40 ligand sCD154 in systemic lupus erythematosus.
Kato K; Santana-Sahagún E; Rassenti LZ; Weisman MH; Tamura N; Kobayashi S; Hashimoto H; Kipps TJ
J Clin Invest; 1999 Oct; 104(7):947-55. PubMed ID: 10510335
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus.
Blossom S; Chu EB; Weigle WO; Gilbert KM
J Immunol; 1997 Nov; 159(9):4580-6. PubMed ID: 9379059
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J
J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147
[TBL] [Abstract][Full Text] [Related]
18. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
Grammer AC; Slota R; Fischer R; Gur H; Girschick H; Yarboro C; Illei GG; Lipsky PE
J Clin Invest; 2003 Nov; 112(10):1506-20. PubMed ID: 14617752
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
20. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
